Trade Summary

1 week ago, Smith Stan, serving as Dir at Maia Biotechnology, Inc. (MAIA), purchased 57,189 shares at $1.22 per share, for a total transaction value of $69,999.00. Following this transaction, Smith Stan now holds 1,435,218 shares of MAIA.

This purchase represents a 4.00% increase in Smith Stan's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, December 22, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 23, 2025, 1 day after the trade was made.

Maia Biotechnology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.